Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 11,141–11,160 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

Trimix Injectable 30 mg/3 mg/60 mcg/mL, a) 2 mL, b) 5 mL and c) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Injectable 30 mg/3 mg/100 mcg/mL, a) 5 mL and 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Injectable 30 mg/1 mg/25 mcg/mL, 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Injectable 30 mg/1 mg/10 mcg/mL a) 2 mL and b) 5 mL and c) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Injectable 17.65 mg/0.59 mg/5.9 mcg/mL a) 2 mL, b) 5 mL and c) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Injectable 30 mg/2 mg/20 mcg, a) 5 mL and b) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix Injectable 30 mg/2 mg/40 mcg, 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix with Atropine Injectable 30 mg/3 mg/60 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix with Atropine Injectable 30 mg/3 mg/300 mcg/0.2 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Trimix with Atropine Injectable 30 mg/3 mg/150 mcg/0.2 mg/mL, a) 2 mL b) 5 mL and 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Tri 2 (PAP/PHEN/ATROPINE) NR Injectable, 30 mg/3 mg/0.3 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Tri 1 (PAP/PHEN/ATROPINE) NR Injectable, 3.6 mg/0.4 mg/0.04 mg/mL, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

TitanMax-MIC/12/CA/CH/L/D Injectable 25 mg/50 mg/50/0.5 mg/50 mg/25 mcg/25 mg/25 mg/mL, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Titan Up (INOS/CHOL/LEU/CAR/CHRO/LID) Injectable 25 mg/25 mg/1.5 mg/25 mg/0.025 mg/10 mg/mL, 30 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Propionate Injectable, 100 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate/Anastrozole Injectable, 200 mg/1 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate in Sesame Oil Injectable 200 mg/mL, a) 1 mL and b) 10 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate in Grapeseed Oil Injectable, 20 mg/mL, 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate in Grapeseed Oil Injectable, 100 mg/mL, a) 1mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Testosterone Cypionate / Zinc Sulf in Grapeseed Oil Injectable, 200 mg/200 mcg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason
Lack of Assurance of Sterility
Recall initiated
September 21, 2016
Reported by FDA
January 11, 2017
Distribution
Nationwide

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.